The webinar is now available to watch
Pharma Antitrust: Actavis & Pay-for-Delay Today
Post-Actavis, pharma adapted. Today's pay-for-delay tactics are more sophisticated and harder to identify.
More info
Michael Harary and Tany Sinai discuss the evolution of pay-for-delay cases, the sophisticated tactics pharmaceutical companies now use to obscure anticompetitive conduct, and how data-driven tools help attorneys identify and navigate these cases.
In this session we will cover
- How Actavis transformed antitrust law
- Pharma tactics that evade scrutiny
- Data tools to find pay-for-delay cases
WEBINARS
